CT-011

· CureTech Ltd

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for CT-011, covering 2012-10-23 to 2019-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Gemcitabine and CT-011 for Resected Pancreatic Cancer [Phase 2]